The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. - Wikidata - awgldk - TriplyDB

The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.

The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.

http://www.wikidata.org/entity/Q36031170

about

Diabetes and gastric cancer: the potential links Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies Diabetes mellitus carries a risk of gastric cancer: a meta-analysis Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies Latest insights into the risk of cancer in diabetes Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.Vitamin D intake and type 2 diabetes risk: a meta-analysis of prospective cohort studies.Diabetes and cancer: Associations, mechanisms, and implications for medical practice.Approach to Helicobacter pylori infection in geriatric population.Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Metformin use and lung cancer risk in patients with diabetes.Association of the metformin with the risk of lung cancer: a meta-analysis.Population-based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Associations between Diabetes and Quality of Life among Breast Cancer Survivors.Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis.Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up A Linear Dose-Response Relationship between Fasting Plasma Glucose and Colorectal Cancer Risk: Systematic Review and Meta-analysis.Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.Association of diabetes and diabetes treatment with incidence of breast cancer.Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism.Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.

P2860

Q24602836-2A6B29EF-0C99-4D6F-B381-49FCE264D602 Q26823071-636FCEA1-A4A4-4C75-B261-2941C2CA89C3 Q26825127-BF47318F-DDCE-468E-AFF4-C63A9BD48879 Q27008886-E653D6BA-3BE5-48EA-BB3E-8C29D082AB72 Q27026428-DCFCCB82-CAAB-4174-A47D-192F348424F6 Q28069605-B9597DB9-30EF-490F-8351-D5001BC48D53 Q28542914-25F6E4D5-82AC-4033-88C7-5F5BB1F00271 Q33588852-B1CFCB05-4820-46AA-B42C-ECEDDC72302B Q33672932-47BF44EA-A553-4A96-9FDD-81315B1E671F Q33748862-13D4B8A6-793D-4E7B-9A24-1369A5A8F97E Q33751653-A7AD9B15-67A5-480D-A001-4DEA5DACB159 Q33759594-835B99B4-06C2-4291-949F-E9BCBDC6BC1A Q34047658-BDFE9F65-0B7A-4831-9473-A1BCE9663E29 Q34065281-97B14794-4E74-4EF4-8E09-3D6DB4B1CBB2 Q34135248-729F937F-AFE5-4F8D-91A3-5E75FECCFFC9 Q35038355-3D63FBBF-AE6D-432A-A4A7-5DCF49F9E904 Q35046673-791F4A60-F5D6-4511-980B-49CE97D6877A Q35200421-CED3DEAC-03F0-45A8-A766-D4981B828F5D Q35217822-B21E682C-790E-4EBF-97E3-EBEC2C4F91EB Q35838633-6756FCDC-EEE8-4DAD-B803-A367E50CE429 Q35937961-0C1410C4-C33A-4DF5-B0B8-D1BD1ECEAB77 Q36059119-DABF685A-E0AA-4487-8E40-718C39A1EA34 Q36145731-1CF18965-C1FF-4076-A50D-EC42E24A001A Q36209639-D379F80C-D5C1-4115-A7AB-DD6DAF017F1F Q36334211-1AAA740E-72E2-4AB7-9704-125A66FDA023 Q36370966-9BCC683E-6135-423D-A0A3-1435D4280C0F Q36568614-75C9BA32-415B-4BB2-B9D4-0648A23E17BC Q36582700-23A4C957-A9FD-4E03-A1FA-3ECF1400218D Q36694319-42F9C48F-2BEE-4173-A52D-99C4A91418C9 Q37228939-5E31D229-F498-456E-AF8A-F209A7E8839B Q37274957-92925D37-E2D4-46A2-8180-1548DBA1CF58 Q37328209-2BDA243A-4E68-4528-BD71-969437926016 Q37709423-43685BAE-B1D8-4EF1-8BDA-4613EDA91ACC Q37745840-BA6A79C6-5985-411E-A884-D62909A036AB Q37745926-7F3B3058-7A29-45BC-9D7C-5DCDB0590EBA Q38668187-D950D8AC-056A-4EE6-A8BB-A7AF21A4201A Q38858585-55C4E59F-3BD4-425C-AF29-6BFEB941BC58 Q38885892-720DE2D2-841F-4C35-977E-041EEDEF017A Q38976502-2974FABD-8628-412A-BEE8-E8139044EA46 Q38999875-FEDF4F4D-1022-407D-A50F-D5F265D7E9CC

P2860

The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.

http://www.wikidata.org/entity/Q36031170

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@ast

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@en

type

label

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@ast

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@en

prefLabel

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@ast

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@en

P1433

Q36031170-49A83AD3-4802-4110-A6B9-B480D6AEED88

P1476

Q36031170-2EB5F6BB-5499-4A02-9AEB-91C01F18A749

P2093

Q36031170-106447BD-AC4C-4B42-87C0-F7DA46633776

Q36031170-380110E1-AA87-471E-B983-C712B7D5F842

Q36031170-40A2F0BF-6628-4FA7-A23F-AEBC2952924E

Q36031170-84793B9E-9563-4F41-A634-32BAE723C7DC

Q36031170-D5C06980-A1B9-4791-B71F-497A93AA9E0E

Q36031170-E1E8B6FF-FC24-4D58-9AC3-55092596DBA3

P2860

Q36031170-018BAF9E-F192-4A66-A638-63EBAE5721AF

Q36031170-0267E683-9852-4366-B99B-30D23B0E1AD2

Q36031170-14C66640-AF0B-4060-B54C-4792A88C956D

Q36031170-2AD9FF3F-3584-42A2-BE35-3D397FBE534E

Q36031170-2B20C034-7AD4-4E85-9587-4F967D701A9D

Q36031170-3CFBE895-1BD0-446F-80E4-F8BE8D9480DF

Q36031170-42814B43-27F7-4DC0-BFC5-6B5E27F6ACD0

Q36031170-436A33A8-6C95-4D5F-AB77-410DB27F6609

Q36031170-5084FBDF-1464-4F8C-865A-68856D4AFFBE

Q36031170-628A7E61-BEAB-47FD-94C1-C8E4F05563FE

P304

Q36031170-ECEEAB8E-29C1-437F-BB3F-93658B639912

P31

Q36031170-E4455B0A-1216-42EB-9B6D-172C11DD1015

P356

Q36031170-D22069BF-B4DE-4B2C-B3AB-846AFCC86C6A

P478

Q36031170-2E9392DF-0A57-4D8D-A88E-DD973A0B9BE2

P577

Q36031170-5065BC24-813E-4CE1-9542-927D853DA2E0

P5875

Q36031170-A5039687-54F8-4857-B5FE-F7DB9C69D311

P698

Q36031170-4F30E693-44B1-4804-9373-5C01955C9D9E

P921

Q36031170-175CE6C9-2F7C-49F2-B30B-BCE7DAA3E4BC

P932

Q36031170-68C0EBFE-1503-4A28-A983-E04928C0CBD9

P356

P1433

Experimental Diabetes Research

P1476

The influence of type 2 diabet ...... cancer risk in the Taiwanese.

@en

P2093

Chin-Hsiao Tseng

http://www.w3.org/2001/XMLSchema#string

Ming-Chia Hsieh

http://www.w3.org/2001/XMLSchema#string

Ming-Hong Yen

http://www.w3.org/2001/XMLSchema#string

Shih-Te Tu

http://www.w3.org/2001/XMLSchema#string

Shu-Min Cheng

http://www.w3.org/2001/XMLSchema#string

Tzu-Chi Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Oral Antidiabetic Agents

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

Insulin and insulin-like growth factor signalling in neoplasia

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Diabetes and risk of prostate cancer: a study using the National Health Insurance.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Diabetes mellitus and risk of breast cancer: a meta-analysis.

Pioglitazone and bladder cancer: a population-based study of Taiwanese.

P304

413782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/413782

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227712214

http://www.w3.org/2001/XMLSchema#string

P698

22719752

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3374948

http://www.w3.org/2001/XMLSchema#string